0002124719-26-000001.txt : 20260421
0002124719-26-000001.hdr.sgml : 20260421
20260421160240
ACCESSION NUMBER: 0002124719-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260421
DATE AS OF CHANGE: 20260421
EFFECTIVENESS DATE: 20260421
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Haylex Laboratories Inc.
CENTRAL INDEX KEY: 0002124719
ORGANIZATION NAME:
EIN: 851900686
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-581307
FILM NUMBER: 26879328
BUSINESS ADDRESS:
STREET 1: 2317 TRAILS END, KERRVILLE, TX 78028
CITY: KERRVILLE
STATE: TX
ZIP: 78028
BUSINESS PHONE: 830-431-2759
MAIL ADDRESS:
STREET 1: 2317 TRAILS END
CITY: KERRVILLE
STATE: TX
ZIP: 78028
D
1
primary_doc.xml
X0708
D
LIVE
0002124719
Haylex Laboratories Inc.
2317 TRAILS END
KERRVILLE
TX
TEXAS
78028
830-431-2759
TEXAS
None
None
Corporation
true
2026
Mark
Stephen
Malone
2317 Trails End
Kerrville
TX
TEXAS
78028
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-04-15
false
true
false
0
1500000
50000
1450000
false
1
0
0
0
A portion of proceeds may be used to pay compensation to executive officers.
false
Haylex Laboratories Inc.
Mark Stephen Malone
Mark Stephen Malone
President
2026-04-14